divalproex sodium

Generic: divalproex sodium

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name divalproex sodium
Generic Name divalproex sodium
Labeler bluepoint laboratories
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

divalproex sodium 250 mg/1

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-473
Product ID 68001-473_4b029245-2b01-8812-e063-6394a90afff8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA079163
Listing Expiration 2027-12-31
Marketing Start 2021-01-20

Pharmacologic Class

Classes
anti-epileptic agent [epc] decreased central nervous system disorganized electrical activity [pe] mood stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001473
Hyphenated Format 68001-473

Supplemental Identifiers

RxCUI
1099625 1099678 1099870
UPC
0368001474009 0368001473002 0368001472005
UNII
644VL95AO6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name divalproex sodium (source: ndc)
Generic Name divalproex sodium (source: ndc)
Application Number ANDA079163 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (68001-473-00)
  • 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (68001-473-03)
source: ndc

Packages (2)

68001-473-00 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (68001-473-00) 68001-473-03 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (68001-473-03)

Ingredients (1)

divalproex sodium (250 mg/1)

Linked Drug Pages (1)

Divalproex Sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4b029245-2b01-8812-e063-6394a90afff8", "openfda": {"upc": ["0368001474009", "0368001473002", "0368001472005"], "unii": ["644VL95AO6"], "rxcui": ["1099625", "1099678", "1099870"], "spl_set_id": ["b95494e2-ee7a-7415-e053-2995a90ae852"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (68001-473-00)", "package_ndc": "68001-473-00", "marketing_start_date": "20210120"}, {"sample": false, "description": "500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (68001-473-03)", "package_ndc": "68001-473-03", "marketing_start_date": "20210120"}], "brand_name": "Divalproex Sodium", "product_id": "68001-473_4b029245-2b01-8812-e063-6394a90afff8", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "68001-473", "generic_name": "Divalproex Sodium", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA079163", "marketing_category": "ANDA", "marketing_start_date": "20210120", "listing_expiration_date": "20271231"}